DNA X, Inc. (SONM) Financial Ratio Screen

NASDAQ Technology United States USD 5M
INSUFFICIENT / NOT IMPLEMENTED*
Automated financial screen · activity assessed separately
DNA X, Inc. (SONM) needs additional financial data before the automated screen can be completed. One or more financial fields are missing; this is not a negative screening result.

Track SONM screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

SONM financial screening at a glance

INSUFFICIENT / NOT IMPLEMENTED*Financial ratios shown separately from business review — not a fatwa
Debt ratio
N/A
Not available vs 30%
Cash ratio
13.4%
Pass vs 30%
Receivables + cash
42.7%
Fail vs 30%
Impermissible income
N/A
Not available vs 5%

Calculation date: 2026-09-01. Financial period used: December 2024. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleMore financial data neededNo negative conclusion follows from missing data
FTSE/Yasaar-styleMore financial data neededNo negative conclusion follows from missing data
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2024Calculation date2026-09-01S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Software - Infrastructure) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim XP Pro; XP100 4G and XP400 5G professional rugged phones; XP Pro 5G rugged smartphones; and XP3plus 5G rugged flip phones. It also provides connected solutions comprising fixed wireless access and mobile hotspot devices, such as Sonim H100 low- and mid-range mobile hotspots; Sonim H700; and Sonim H500-series of 5G mobile hotspots. In addition, the company offers SonimWare software and industrial-grade accessories. It sells its products through wireless carriers, distributors of data devices, communications system integrators, and electronics resellers. The company serves the transportation and logistics, construction, manufacturing, facilities management, energy and utility, mining, federal government, and public safety sectors. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI N/A 13.4%
/ 30%
42.7%
/ 30%
N/A INSUFFICIENT / NOT IMPLEMENTED*
FTSE N/A 13.4%
/ 33%
42.7%
/ 50%
N/A INSUFFICIENT / NOT IMPLEMENTED*

Financial Highlights

EPS
$-100.98
P/B Ratio
-4.8
EV/EBITDA
-0.2
EV: $6M
Revenue
$58M
Growth: 7.9%
Beta
1.7
High volatility
Current Ratio
0.8

Profitability

Gross Margin 17.9%
Operating Margin -24.5%
Net Margin -56.5%
Return on Equity (ROE) -455.8%
Return on Assets (ROA) -44.3%

Cash Flow & Balance Sheet

Operating Cash Flow-$8M
Free Cash Flow-$9M
Current Ratio0.8
Total Assets$40M

Price & Trading

Last Close$2.82
50-Day MA$5.01
200-Day MA$9.50
Avg Volume58K
Beta1.7
52-Week Range
$2.52
$61.00

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2024. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About DNA X, Inc. (SONM)

CEO
Mr. Michael C. Mulica
Employees
131
Sector
Technology
Industry
Software - Infrastructure
Country
United States
Exchange
NASDAQ
Market Cap (listing currency)
USD 5M
Currency
USD

DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim XP Pro; XP100 4G and XP400 5G professional rugged phones; XP Pro 5G rugged smartphones; and XP3plus 5G rugged flip phones. It also provides connected solutions comprising fixed wireless access and mobile hotspot devices, such as Sonim H100 low- and mid-range mobile hotspots; Sonim H700; and Sonim H500-series of 5G mobile hotspots. In addition, the company offers SonimWare software and industrial-grade accessories. It sells its products through wireless carriers, distributors of data devices, communications system integrators, and electronics resellers. The company serves the transportation and logistics, construction, manufacturing, facilities management, energy and utility, mining, federal government, and public safety sectors. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is DNA X, Inc. (SONM) halal to invest in?

The current automated result is More financial data is needed. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is DNA X, Inc.'s debt ratio?

DNA X, Inc.'s debt ratio is not available in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are DNA X, Inc.'s key financial metrics?

DNA X, Inc. has a market capitalization of USD 5M in its listing currency, and revenue of $58M. The company maintains a gross margin of 17.9% and a net margin of -56.5%. Return on equity stands at -455.8%.

How often is the screening data updated?

Calculation date: 2026-09-01. Financial period: December 2024. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.